86 related articles for article (PubMed ID: 1532232)
21. Diagnostic utility of quantitating neurofilament-immunoreactive Alzheimer's disease lesions.
de la Monte SM; Wands JR
J Histochem Cytochem; 1994 Dec; 42(12):1625-34. PubMed ID: 7983363
[TBL] [Abstract][Full Text] [Related]
22. Disintegration of the spatial organization of behavior in experimental autoimmune dementia.
Eilam D; Szechtman H; Faigon M; Dubovik V; Feldon J; Michaelson DM
Neuroscience; 1993 Sep; 56(1):83-91. PubMed ID: 8232920
[TBL] [Abstract][Full Text] [Related]
23. Neuronal and glial gene expression in neocortex of Down's syndrome and Alzheimer's disease.
Goodison KL; Parhad IM; White CL; Sima AA; Clark AW
J Neuropathol Exp Neurol; 1993 May; 52(3):192-8. PubMed ID: 8492138
[TBL] [Abstract][Full Text] [Related]
24. Immunologic dysfunction: simultaneous study of Alzheimer's and older Down's patients.
Singh VK; Fudenberg HH; Brown FR
Mech Ageing Dev; 1986-1987 Jan; 37(3):257-64. PubMed ID: 2952844
[TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome.
Heinonen O; Syrjänen S; Soininen H; Talasniemi S; Kaski M; Mäntyjärvi R; Syrjänen K; Riekkinen P
Neurosci Lett; 1993 Jan; 149(1):67-70. PubMed ID: 8469384
[TBL] [Abstract][Full Text] [Related]
26. Detection of brain autoantibodies in the serum of patients with Alzheimer's disease but not Down's syndrome.
Singh VK; Fudenberg HH
Immunol Lett; 1986 Jun; 12(5-6):277-80. PubMed ID: 2942467
[TBL] [Abstract][Full Text] [Related]
27. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing.
van Gool WA; Evenhuis HM; van Duijn CM
Ann Neurol; 1995 Aug; 38(2):225-30. PubMed ID: 7654070
[TBL] [Abstract][Full Text] [Related]
28. Training to criterion in eyeblink classical conditioning in Alzheimer's disease, Down's syndrome with Alzheimer's disease, and healthy elderly.
Woodruff-Pak DS; Romano S; Papka M
Behav Neurosci; 1996 Feb; 110(1):22-9. PubMed ID: 8652068
[TBL] [Abstract][Full Text] [Related]
29. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
[TBL] [Abstract][Full Text] [Related]
30. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
[TBL] [Abstract][Full Text] [Related]
31. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
[TBL] [Abstract][Full Text] [Related]
32. Immunological studies of patients with Down's syndrome. Measurements of autoantibodies and serum antibodies to dietary antigens in relation to zinc levels.
Kanavin O; Scott H; Fausa O; Ek J; Gaarder PI; Brandtzaeg P
Acta Med Scand; 1988; 224(5):473-7. PubMed ID: 2974234
[TBL] [Abstract][Full Text] [Related]
33. Abnormal serum IgG subclass pattern in children with Down's syndrome.
Annerén G; Magnusson CG; Lilja G; Nordvall SL
Arch Dis Child; 1992 May; 67(5):628-31. PubMed ID: 1534650
[TBL] [Abstract][Full Text] [Related]
34. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
[TBL] [Abstract][Full Text] [Related]
35. Down's syndrome and Alzheimer's dementia: defining an association.
Heston LL
Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
37. A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease.
Bodhireddy S; Dickson DW; Mattiace L; Weidenheim KM
Neurology; 1994 Jan; 44(1):159-61. PubMed ID: 8290054
[TBL] [Abstract][Full Text] [Related]
38. Immunization of rats with cholinergic neurons induces behavioral deficits.
Chapman J; Feldon J; Alroy G; Michaelson DM
J Neural Transplant; 1989; 1(2):63-76. PubMed ID: 2519521
[TBL] [Abstract][Full Text] [Related]
39. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.
Portelius E; Soininen H; Andreasson U; Zetterberg H; Persson R; Karlsson G; Blennow K; Herukka SK; Mattsson N
Neurodegener Dis; 2014; 14(2):98-106. PubMed ID: 24992945
[TBL] [Abstract][Full Text] [Related]
40. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders.
Smith TW; Lippa CF
J Neuropathol Exp Neurol; 1995 May; 54(3):297-303. PubMed ID: 7745428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
